Molecular targets for flavivirus drug discovery

Antiviral Research

Volumn 81, Issue 1, 2009, Pages 6-15

  Sampath, Aruna ^a   Padmanabhan, R ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiviral therapy; Dengue virus; Envelope glycoprotein; Flavivirus; Helicase; Japanese encephalitis virus; Methyltransferase; Protease; RNA dependent RNA polymerase; West Nile virus; Yellow fever virus

Indexed keywords

ADENOSYLHOMOCYSTEINASE INHIBITOR; ANTIVIRUS AGENT; E PROTEIN; M PROTEIN; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5; NUCLEOSIDE; NUCLEOSIDE ANALOG; POLYMERASE INHIBITOR; PROTEIN C; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED RNA POLYMERASE; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

DENGUE VIRUS; EBOLA VIRUS; FLAVIVIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRION; VIRUS GENOME; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; DRUG DISCOVERY; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; GENOME, VIRAL; HUMANS; VIRAL PROTEINS;

DENGUE VIRUS; FLAVIVIRUS; IXODIDA; JAPANESE ENCEPHALITIS VIRUS; MURINAE; WEST NILE VIRUS; YELLOW FEVER VIRUS;

EID: 57149088067     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.08.004     Document Type: Review

References (168)

1. Ackermann M., and Padmanabhan R. De novo synthesis of RNA by the dengue virus RNA-dependent RNA polymerase exhibits temperature dependence at the initiation but not elongation phase. J. Biol. Chem. 276 (2001) 39926-39937
2. Aleshin A.E., Shiryaev S.A., Strongin A.Y., and Liddington R.C. Structural evidence for regulation and specificity of flaviviral proteases and evolution of the Flaviviridae fold. Protein Sci. 16 (2007) 795-806
3. Allison S.L., Schalich J., Stiasny K., Mandl C.W., Kunz C., and Heinz F.X. Oligomeric rearrangement of tick-borne encephalitis-virus envelope proteins induced by an acidic pH. J. Virol. 69 (1995) 695-700
4. Arias C.F., Preugschat F., and Strauss J.H. Dengue-2 virus NS2b and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology 193 (1993) 888-899
5. Barba-Spaeth G., Longman R.S., Albert M.L., and Rice C.M. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J. Exp. Med. 202 (2005) 1179-1184
6. Barklis E., Still A., Sabri M.I., Hirsch A.J., Nikolich-Zugich J., Brien J., Dhenub T.C., Scholz I., and Alfadhli A. Sultam thiourea inhibition of West Nile virus. Antimicrob. Agents Chemother. 51 (2007) 2642-2645
7. Bartholomeusz A.I., and Wright P.J. Synthesis of dengue virus RNA in vitro-initiation and the involvement of proteins NS3 and NS5. Arch. Virol. 128 (1993) 111-121
8. Bazan J.F., and Fletterick R.J. Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. Virology 171 (1989) 637-639
9. 2+-dependent and require a functional Walker B motif in the helicase catalytic core. Virology 328 (2004) 208-218
10. Bera A.K., Kuhn R.J., and Smith J.L. Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease. J. Biol. Chem. 282 (2007) 12883-12892
11. Blackwell J.L., and Brinton M.A. Translation elongation factor-1 alpha interacts with the 3' stem-loop region of West Nile virus genomic RNA. J Virol. 71 (1997) 6433-6444
12. Borowski P., Lang M., Haag A., Schmitz H., Choe J., Chen H.M., and Hosmane R.S. Characterization of imidazo 4,5-d pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase: evidence for activity on the level of substrate and/or enzyme. Antimicrob. Agents Chemother. 46 (2002) 1231-1239
13. Borowski P., Deinert J., Schalinski S., Bretner M., Ginalski K., Kulikowski T., and Shugar D. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses. Eur. J. Biochem. 270 (2003) 1645-1653
14. Borowski P., Lang M., Haag A., and Baier A. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase. Antivir. Chem. Chemother. 18 (2007) 103-109
15. Bray M. Highly pathogenic RNA viral infections: challenges for antiviral research. Antiviral Res. 78 (2008) 1-8
16. Bray M., Driscoll J., and Huggins J.W. Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-l-homocysteine hydrolase inhibitor. Antiviral Res. 45 (2000) 135-147
17. Bridges S. Basic science priorities for therapeutics research. Res. Initiat. Treat. Action 8 (2003) 25-27
18. Brinton M.A. Host factors involved in West Nile virus replication. Ann N Y Acad Sci. 951 (2001) 207-219
19. Cameron C.E., and Castro C. The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Curr. Opin. Infect. Dis. 14 (2001) 757-764
20. Cammack N. The potential for HIV fusion inhibition. Curr. Opin. Infect. Dis. 14 (2001) 13-16
21. Carta A., Loriga G., Piras S., Paglietti G., Ferrone M., Fermeglia M., Pricl S., La Colla P., Secci B., Collu G., and Loddo R. Synthesis and in vitro evaluation of the anti-viral activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides. Med. Chem. 2 (2006) 577-589
22. Chambers T.J., Weir R.C., Grakoui A., McCourt D.W., Bazan J.F., Fletterick R.J., and Rice C.M. Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 8898-8902
23. Chambers T.J., Grakoui A., and Rice C.M. Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J. Virol. 65 (1991) 6042-6050
24. Chambers T.J., Nestorowicz A., Amberg S.M., and Rice C.M. Mutagenesis of the yellow fever virus NS2B protein: effects on proteolytic processing, NS2B-NS3 complex formation, and viral replication. J. Virol. 67 (1993) 6797-6807
25. Chanprapaph S., Saparpakorn P., Sangma C., Niyomrattanakit P., Hannongbua S., Angsuthanasombat C., and Katzenmeier G. Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites. Biochem. Biophys. Res. Commun. 330 (2005) 1237-1246
26. Chappell K.J., Nall T.A., Stoermer M.J., Fang N.X., Tyndall J.D., Fairlie D.P., and Young P.R. Site-directed mutagenesis and kinetic studies of the West Nile Virus NS3 protease identify key enzyme-substrate interactions. J. Biol. Chem. 280 (2005) 2896-2903
27. Chappell K.J., Stoermer M.J., Fairlie D.P., and Young P.R. Insights to substrate binding and processing by West Nile Virus NS3 protease through combined modeling, protease mutagenesis, and kinetic studies. J. Biol. Chem. 281 (2006) 38448-38458
28. Chappell K.J., Stoermer M.J., Fairlie D.P., and Young P.R. Generation and characterization of proteolytically active and highly stable truncated and full-length recombinant West Nile virus NS3. Protein Exp. Purif. 53 (2007) 87-96
29. Charlier N., Leyssen P., De Clercq E., and Neyts J. Rodent models for the study of therapy against flavivirus infections. Antiviral Res. 63 (2004) 67-77
30. Chu P.W.G., and Westaway E.G. Characterization of Kunjin virus RNA-dependent RNA-polymerase-reinitiation of synthesis in vitro. Virology 157 (1987) 330-337
31. Chu P.W.G., and Westaway E.G. Molecular and ultrastructural analysis of heavy membrane-fractions associated with the replication of Kunjin virus RNA. Arch. Virol. 125 (1992) 177-191
32. Citterio P., and Rusconi S. Novel inhibitors of the early steps of the HIV-1 life cycle. Exp. Opin. Investig. Drugs 16 (2007) 11-23
33. Clum S., Ebner K.E., and Padmanabhan R. Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3(Pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B. J. Biol. Chem. 272 (1997) 30715-30723
34. Crotty S., and Andino R. Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin. Microbes Infect. 4 (2002) 1301-1307
35. Crotty S., Cameron C.E., and Andino R. RNA virus error catastrophe: direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 6895-6900
36. Crotty S., Cameron C., and Andino R. Ribavirin's antiviral mechanism of action: lethal mutagenesis?. J. Mol. Med. 80 (2002) 86-95
37. Daelemans D., Lu R., De Clercq E., and Engelman A. Characterization of a replication-competent, integrase-defective human immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the discovery and validation of HIV integrase inhibitors. J. Virol. 81 (2007) 4381-4385
38. Davis W.G., Blackwell J.L., Shi P.Y., and Brinton M.A. Interaction between the cellular protein eEF1A and the 3'-terminal stem-loop of West Nile virus genomic RNA facilitates viral minus-strand RNA synthesis. J Virol. 81 (2007) 10172-10187
39. DeMarco S.J., Henze H., Lederer A., Moehle K., Mukherjee R., Romagnoli B., Robinson J.A., Brianza F., Gombert F.O., Lociuro S., Ludin C., Vrijbloed J.W., Zumbrunn J., Obrecht J.P., Obrecht D., Brondani V., Hamy F., and Klimkait T. Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles. Bioorg. Med. Chem. 14 (2006) 8396-8404
40. De Nova-Ocampo M., Villegas-Sepulveda N., and del Angel R.M. Translation elongation factor-1alpha, La, and PTB interact with the 3' untranslated region of dengue 4 virus RNA. Virology 295 (2002) 337-347
41. Dong H.P., Ray D., Ren S.P., Zhang B., Puig-Basagoiti F., Takagi Y., Ho C.K., Li H.M., and Shi P.Y. Distinct RNA elements confer specificity to flavivirus RNA cap methylation events. J. Virol. 81 (2007) 4412-4421
42. Dong H., Zhang B., and Shi P.-Y. Flavivirus methyltransferase: a novel antiviral target. Antiviral Res. 80 1 (2008) 1-10
43. Egloff M.P., Benarroch D., Selisko B., Romette J.L., and Canard B. An RNA cap (nucleoside-2′-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization. EMBO J. 21 (2002) 2757-2768
44. Egloff M.P., Decroly E., Malet H., Selisko B., Benarroch D., Ferron F., and Canard B. Structural and functional analysis of methylation and 5′-RNA sequence requirements of short capped RNAs by the methyltransferase domain of dengue virus NS5. J. Mol. Biol. 372 (2007) 723-736
45. Emara M.M., and Brinton M.A. Interaction of TIA-1/TIAR with West Nile and dengue virus products in infected cells interferes with stress granule formation and processing body assembly. Proc Natl Acad Sci U. S. A. 104 (2007) 9041-9046
46. Erbel P., Schiering N., D'Arcy A., Renatus M., Kroemer M., Lim S.P., Yin Z., Keller T.H., Vasudevan S.G., and Hommel U. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat. Struct. Mol. Biol. 13 (2006) 372-373
47. Falgout B., Pethel M., Zhang Y.M., and Lai C.J. Both nonstructural proteins NS2b and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J. Virol. 65 (1991) 2467-2475
48. Falgout B., Miller R.H., and Lai C.-J. Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J. Virol. 67 (1993) 2034-2042
49. Frick D.N. Helicases as antiviral drug targets. Drug News Perspect. 16 (2003) 355-362
50. Frick D.N. The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target. Curr. Issues Mol. Biol. 9 (2007) 1-20
51. Garcia-Montalvo B.M., Medina F., and del Angel R.M. La protein binds to NS5 and NS3 and to the 5' and 3' ends of Dengue 4 virus RNA. Virus Res. 102 (2004) 141-150
52. Gorbalenya A.E., Donchenko A.P., Koonin E.V., and Blinov V.M. N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res. 17 (1989) 3889-3897
53. Gouvea I.E., Izidoro M.A., Judice W.A., Cezari M.H., Caliendo G., Santagada V., dos Santos C.N., Queiroz M.H., Juliano M.A., Young P.R., Fairlie D.P., and Juliano L. Substrate specificity of recombinant dengue 2 virus NS2B-NS3 protease: influence of natural and unnatural basic amino acids on hydrolysis of synthetic fluorescent substrates. Arch. Biochem. Biophys. 457 (2007) 187-196
54. Graci J.D., Harki D.A., Korneeva V.S., Edathil J.P., Too K., Franco D., Smidansky E.D., Paul A.V., Peterson B.R., Brown D.M., Loakes D., and Cameron C.E. Lethal mutagenesis of poliovirus mediated by a mutagenic pyrimidine analogue. J. Virol. 81 (2007) 11256-11266
55. Grun J.B., and Brinton M.A. Characterization of West Nile virus RNA-dependent RNA polymerase and cellular terminal adenylyl and uridylyl transferases in cell-free extracts. J. Virol. 60 (1986) 1113-1124
56. Grun J.B., and Brinton M.A. Characterization of West Nile virus RNA-dependent RNA polymerase and cellular terminal adenylyl and uridylyl transferases in cell-free extracts. J. Virol. 60 (1986) 1103-1124
57. Gubler D., Kuno G., and Markoff L. Flaviviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 5th ed. 1 (2007), Lippincott William & Wilkins, Philadelphia, PA 1153-1253
58. Guyatt K.J., Westaway E.G., and Khromykh A.A. Expression and purification of enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the flavivirus Kunjin. J. Virol. Methods 92 (2001) 37-44
59. Holbrook M.R., and Gowen B.B. Animal models of highly pathogenic RNA viral infections: encephalitis viruses. Antiviral Res. 78 (2008) 69-78
60. Jensen D.M., and Ascione A. Future directions in therapy for chronic hepatitis C. Antiviral Ther. 13 Suppl. 1 (2008) 31-36
61. Johansson M., Brooks A.J., Jans D.A., and Vasudevan S.G. A small region of the dengue virus-encoded RNA-dependent RNA polymerase, NS5, confers interaction with both the nuclear transport receptor importin-beta and the viral helicase, NS3. J. Gen. Virol. 82 (2001) 735-745
62. Johansson A., Poliakov A., Akerblom E., Wiklund K., Lindeberg G., Winiwarter S., Danielson U.H., Samuelsson B., and Hallberg A. Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals. Bioorg. Med. Chem. 11 (2003) 2551-2568
63. Johnston P.A., Phillips J., Shun T.Y., Shinde S., Lazo J.S., Huryn D.M., Myers M.C., Ratnikov B.I., Smith J.W., Su Y., Dahl R., Cosford N.D.P., Shiryaev S.A., and Strongin A.Y. HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus. Assay Drug Dev. Technol. 5 (2007) 737-750
64. Jones C.T., Ma L.X., Burgner J.W., Groesch T.D., Post C.B., and Kuhn R.J. Flavivirus capsid is a dimeric alpha-helical protein. J. Virol. 77 (2003) 7143-7149
65. Kajaste-Rudnitski A., Mashimo T., Frenkiel M.P., Guenet J.L., Lucas M., and Despres P. The 2′,5′-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells. J. Biol. Chem. 281 (2006) 4624-4637
66. Kazmierski W.M., Kenakin T.P., and Gudmundsson K.S. Peptide, peptidomimetic and small-molecule drug discovery targeting HIV-1 host-cell attachment and entry through gp120, gp41, CCR5 and CXCR4. Chem. Biol. Drug Des. 67 (2006) 13-26
67. Khromykh A.A., and Westaway E.G. RNA binding properties of core protein of the flavivirus Kunjin. Arch. Virol. 141 (1996) 685-699
68. Khumthong R., Angsuthanasombat C., Panyim S., and Katzenmeier G. In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates. J. Biochem. Mol. Biol. 35 (2002) 206-212
69. Khumthong R., Niyomrattanakit P., Chanprapaph S., Angsuthanasombat C., Panyim S., and Katzenmeier G. Steady-state cleavage kinetics for dengue virus type 2 ns2b-ns3(pro) serine protease with synthetic peptides. Protein Pept. Lett. 10 (2003) 19-26
70. Kiermayr S., Kofler R.M., Mandl C.W., Messner P., and Heinz F.X. Isolation of capsid protein dimers from the tick-borne encephalitis flavivirus and in vitro assembly of capsid-like particles. J. Virol. 78 (2004) 8078-8084
71. Knox J.E., Ma N.L., Yin Z., Patel S.J., Wang W.L., Chan W.L., Ranga Rao K.R., Wang G., Ngew X., Patel V., Beer D., Lim S.P., Vasudevan S.G., and Keller T.H. Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors. J. Med. Chem. 49 (2006) 6585-6590
72. Krishnan M.N., Sukumaran B., Pal U., Agaisse H., Murray J.L., Hodge T.W., and Fikrig E. Rab 5 is required for the cellular entry of dengue and West Nile viruses. J. Virol. 81 (2007) 4881-4885
73. Lescar J., Dahai L., Xu T., Sampath A., Lim S.P., Canard B., and Vasudevan S.G. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res. 80 (2008) 94-101
74. Leung D., Schroder K., White H., Fang N.X., Stoermer M.J., Abbenante G., Martin J.L., Young P.R., and Fairlie D.P. Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors. J. Biol. Chem. 276 (2001) 45762-45771
75. Leung J.Y., Pijlman G.P., Kondratieva N., Hyde J., Mackenzie J.M., and Khromykh A.A. Role of nonstructural protein NS2A in flavivirus assembly. J. Virol. 82 (2008) 4731-4741
76. Leyssen P., De Clercq E., and Neyts J. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication. Mol. Pharmacol. 69 (2006) 1461-1467
77. Leyssen P., De Clercq E., and Neyts J. Molecular strategies to inhibit the replication of RNA viruses. Antiviral Res. 78 (2008) 9-25
78. Li H., Clum S.R., You S., Ebner K.E., and Padmanabhan R. The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids. J. Virol. 73 (1999) 3108-3116
79. Li W., Li Y., Kedersha N., Anderson P., Emara M., Swiderek K.M., Moreno G.T., and Brinton M.A. Cell proteins TIA-1 and TIAR interact with the 3' stem-loop of the West Nile virus complementary minus-strand RNA and facilitate virus replication. J Virol. 76 (2002) 11989-12000
80. Li J., Lim S.P., Beer D., Patel V., Wen D.Y., Tumanut C., Tully D.C., Williams J.A., Jiricek J., Priestle J.P., Harris J.L., and Vasudevan S.G. Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J. Biol. Chem. 280 (2005) 28766-28774
81. Li L., Lok S.M., Yu I.M., Zhang Y., Kuhn R.J., Chen J., and Rossmann M.G. The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319 (2008) 1830-1834
82. Lindenbach B.D., and Rice C.M. Trans-complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71 (1997) 9608-9617
83. Lindenbach B.D., Thiel H.J., and Rice C.M. Flaviviridae: The Viruses and Their Replication (2007), Lippincott William & Wilkins, Philadelphia, USA
84. Liu-Young G., and Kozal M.J. Review: hepatitis C protease and polymerase inhibitors in development. AIDS Patient Care STDS 22 6 (2008) 449-457
85. Liuzzi M., Mason S.W., Cartier M., Lawetz C., McCollum R.S., Dansereau N., Bolger G., Lapeyre N., Gaudette Y., Lagace L., Massariol M.J., Do F., Whitehead P., Lamarre L., Scouten E., Bordeleau J., Landry S., Rancourt J., Fazal G., and Simoneau B. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase. J. Virol. 79 (2005) 13105-13115
86. Lohr K., Knox J.E., Phong W.Y., Ma N.L., Yin Z., Sampath A., Patel S.J., Wang W.L., Chan W.L., Rao K.R., Wang G., Vasudevan S.G., Keller T.H., and Lim S.P. Yellow fever virus NS3 protease: peptide-inhibition studies. J. Gen. Virol. 88 (2007) 2223-2227
87. Lozach P.Y., Burleigh L., Staropoli I., Navarro-Sanchez E., Harriague J., Virelizier J.L., Rey F.A., Despres P., Arenzana-Seisdedos F., and Amara A. Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J. Biol. Chem. 280 (2005) 23698-23708
88. Luo D., Xu T., Hunke C., Gruber G., Vasudevan S.G., and Lescar J. Crystal structure of the NS3 protease-helicase from dengue virus. J. Virol. 82 (2008) 173-183
89. Luzhkov V.B., Selisko B., Nordqvist A., Peyrane F., Decroly E., Alvarez K., Karlen A., Canard B., and Aqvist J. Virtual screening and bioassay study of novel inhibitors for dengue virus mRNA cap (nucleoside-2′ O)-methyltransferase. Bioorg. Med. Chem. 15 (2007) 7795-7802
90. Ma L.X., Jones C.T., Groesch T.D., Kuhn R.J., and Post C.B. Solution structure of dengue virus capsid protein reveals another fold. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3414-3419
91. Mackenzie J. Wrapping things up about virus RNA replication. Traffic 6 (2005) 967-977
92. MacKenzie J.M., and Westaway E.G. Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J. Virol. 75 (2001) 10787-10799
93. Mackenzie J.M., Khromykh A.A., Jones M.K., and Westaway E.G. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology 245 (1998) 203-215
94. Mackenzie J.S., Gubler D.J., and Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10 (2004) S98-S109
95. Maga G., Gemma S., Fattorusso C., Locatelli G.A., Butini S., Persico M., Kukreja G., Romano M.P., Chiasserini L., Savini L., Novellino E., Nacci V., Spadari S., and Campiani G. Specific targeting of hepatitis C virus NS3 RNA helicase; discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663. Biochemistry 44 (2005) 9637-9644
96. Malet H., Egloff M.P., Selisko B., Butcher R.E., Wright P.J., Roberts M., Gruez A., Sulzenbacher G., Vonrhein C., Bricogne G., Mackenzie J.M., Khromykh A.A., Davidson A.D., and Canard B. Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5. J. Biol. Chem. 282 (2007) 10678-10689
97. Malet H., Massé N., Selisko B., Romette J.-L., Alvarez K., Guillemot J.C., Hughes H., Yap T.H., Vasudevan S., Lescar J., and Canard B. The flavivirus polymerase as a target for drug discovery. Antiviral Res. 80 1 (2008) 23-35
98. Marianneau P., Steffan A.M., Royer C., Drouet M.T., Jaeck D., Kirn A., and Deubel V. Infection of primary cultures of human Kupffer cells by dengue virus: no viral progeny synthesis, but cytokine production is evident. J. Virol. 73 (1999) 5201-5206
99. Mastrangelo E., Milani M., Bollati M., Selisko B., Peyrane F., Pandini V., Sorrentino G., Canard B., Konarev P.V., Svergun D.I., de Lamballerie X., Coutard B., Khromykh A.A., and Bolognesi M. Crystal structure and activity of Kunjin virus NS3 helicase; protease and helicase domain assembly in the full length NS3 protein. J. Mol. Biol. 372 (2007) 444-455
100. Matusan A.E., Kelley P.G., Pryor M.J., Whisstock J.C., Davidson A.D., and Wright P.J. Mutagenesis of the dengue virus type 2 NS3 proteinase and the production of growth-restricted virus. J. Gen. Virol. 82 (2001) 1647-1656
101. Matusan A.E., Pryor M.J., Davidson A.D., and Wright P.J. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication. J. Virol. 75 (2001) 9633-9643
102. Michaelis M., Kleinschmidt M.C., Doerr H.W., and Cinatl Jr. J. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J. Antimicrob. Chemother. 60 5 (2007) 981-986
103. Migliaccio G., Tomassini J.E., Carroll S.S., Tomei L., Altamura S., Bhat B., Bartholomew L., Bosserman M.R., Ceccacci A., Colwell L.F., Cortese R., De Francesco R., Eldrup A.B., Getty K.L., Hou X.S., LaFemina R.L., Ludmerer S.W., MacCoss M., McMasters D.R., Stahlhut M.W., Olsen D.B., Hazuda D.J., and Flores O.A. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J. Biol. Chem. 278 (2003) 49164-49170
104. Miller S., Kastner S., Krijnse-Locker J., Buhler S., and Bartenschlager R. The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J. Biol. Chem. 282 (2007) 8873-8882
105. Mueller N.H., Yon C., Ganesh V.K., and Padmanabhan R. Characterization of the West Nile virus protease substrate specificity and inhibitors. Int. J. Biochem. Cell Biol. 39 (2007) 606-614
106. Mueller N.H., Pattabiraman N., Ansarah-Sobrinho C., Viswanathan P., Pierson T.C., and Padmanabhan R. Identification and biochemical characterization of small molecule inhibitors of West Nile Virus serine protease by a high throughput screen. Antimicrob. Agents Chemother. 52 (2008) 3385-3393
107. Mukhopadhyay S., Kuhn R.J., and Rossmann M.G. A structural perspective of the flavivirus life cycle. Nat. Rev. Microbiol. 3 (2005) 13-22
108. Munch J., Standker L., Adermann K., Schulz A., Schindler M., Chinnadurai R., Pohlmann S., Chaipan C., Biet T., Peters T., Meyer B., Wilhelm D., Lu H., Jing W., Jiang S., Forssmann W.G., and Kirchhoff F. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide. Cell 129 (2007) 263-275
109. Munoz-Jordan J.L., Laurent-Rolle M., Ashour J., Martinez-Sobrido L., Ashok M., Lipkin W.I., and Garcia-Sastre A. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J. Virol. 79 (2005) 8004-8013
110. Muylaert I.R., Galler R., and Rice C.M. Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. J. Virol. 71 (1997) 291-298
111. Nall T.A., Chappell K.J., Stoermer M.J., Fang N.X., Tyndall J.D.A., Young P.R., and Fairlie D.P. Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease. J. Biol. Chem. 279 (2004) 48535-48542
112. Ng C.Y., Gu F., Phong W.Y., Chen Y.L., Lim S.P., Davidson A., and Vasudevan S.G. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Antiviral Res. 76 (2007) 222-231
113. Nomaguchi M., Ackermann M., Yon C., You S., and Padmanbhan R. De novo synthesis of negative-strand RNA by dengue virus RNA-dependent RNA polymerase in vitro: nucleotide, primer, and template parameters. J. Virol. 77 (2003) 8831-8842
114. Nomaguchi M., Teramoto T., Yu L., Markoff L., and Padmanabhan R. Requirements for West Nile virus (-)- and (+)-strand subgenomic RNA synthesis in vitro by the viral RNA-dependent RNA polymerase expressed in Escherichia coli. J. Biol. Chem. 279 (2004) 12141-12151
115. Paeshuyse J., Leyssen P., Mabery E., Boddeker N., Vrancken R., Froeyen M., Ansari I.H., Dutartre H., Rozenski J., Gil L.H., Letellier C., Lanford R., Canard B., Koenen F., Kerkhofs P., Donis R.O., Herdewijn P., Watson J., De Clercq E., Puerstinger G., and Neyts J. A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymerase. J. Virol. 80 (2006) 149-160
116. Pariente N., Airaksinen A., and Domingo E. Mutagenesis versus inhibition in the efficiency of extinction of foot-and-mouth disease virus. J. Virol. 77 (2003) 7131-7138
117. Patkar C.G., Jones C.T., Chang Y.H., Warrier R., and Kuhn R.J. Functional requirements of the yellow fever virus capsid protein. J. Virol. 81 (2007) 6471-6481
118. Perera R., Khaliq M., and Kuhn R.J. Closing the door on flaviviruses: entry as a target for antiviral drug design. Antiviral Res. 80 1 (2008) 11-22
119. Pierson T.C., Sanchez M.D., Puffer B.A., Ahmed A.A., Geiss B.J., Valentine L.E., Altamura L.A., Diamond M.S., and Doms R.W. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346 (2006) 53-65
120. Preugschat F., Yao C.W., and Strauss J.H. In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J. Virol. 64 (1990) 4364-4374
121. Radichev I., Shiryaev S.A., Aleshin A.E., Ratnikov B.I., Smith J.W., Liddington R.C., and Strongin A.Y. Structure-based mutagenesis identifies important novel determinants of the NS2B cofactor of the West Nile virus two-component NS2B-NS3 proteinase. J. Gen. Virol. 89 (2008) 636-641
122. Ray D., and Shi P.Y. Recent advances in flavivirus antiviral drug discovery and vaccine development. Recent Patents Anti-Infect. Drug Disc. 1 (2006) 45-55
123. Ray D., Shah A., Tilgner M., Guo Y., Zhao Y.W., Dong H.P., Deas T.S., Zhou Y.S., Li H.M., and Shi P.Y. West Nile virus 5′-cap structure is formed by sequential guanine N-7 and ribose 2′-O methylations by nonstructural protein 5. J. Virol. 80 (2006) 8362-8370
124. Rice C.M., Lenches E.M., Eddy S.R., Shin S.J., Sheets R.L., and Strauss J.H. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229 (1985) 726-733
125. Roosendaal J., Westaway E.G., Khromykh A., and Mackenzie J.M. Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and Golgi trafficking of the NS4A protein. J. Virol. 80 (2006) 4623-4632
126. Rusconi S., Scozzafava A., Mastrolorenzo A., and Supuran C.T. An update in the development of HIV entry inhibitors. Curr. Top. Med. Chem. 7 (2007) 1273-1289
127. Sampath A., Xu T., Chao A., Luo D.H., Lescar J., and Vasudevan S.G. Structure-based mutational analysis of the NS3 helicase from dengue virus. J. Virol. 80 (2006) 6686-6690
128. Selisko B., Dutartre H., Guillemot J.C., Debarnot C., Benarroch D., Khromykh A., Despres P., Egloff M.P., and Canard B. Comparative mechanistic studies of de novo RNA synthesis by flavivirus RNA-dependent RNA polymerases. Virology 351 (2006) 145-158
129. Shiryaev S.A., Ratnikov B.I., Chekanov A.V., Sikora S., Rozanov D.V., Godzik A., Wang J., Smith J.W., Huang Z., Lindberg I., Samuel M.A., Diamond M.S., and Strongin A.Y. Cleavage targets and the d-arginine-based inhibitors of the West Nile virus NS3 processing proteinase. Biochem. J. 393 (2006) 503-511
130. Shiryaev S.A., Aleshin A.E., Ratnikov B.I., Smith J.W., Liddington R.C., and Strongin A.Y. Expression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B-NS3 junction region. Protein Exp. Purif. 52 (2007) 334-339
131. Shiryaev S.A., Kozlov I.A., Ratnikov B.I., Smith J.W., Lebl M., and Strongin A.Y. Cleavage preference distinguishes the two-component NS2B-NS3 serine proteinases of Dengue and West Nile viruses. Biochem. J. 401 (2007) 743-752
132. Shiryaev S.A., Ratnikov B.I., Aleshin A.E., Kozlov I.A., Nelson N.A., Lebl M., Smith J.W., Liddington R.C., and Strongin A.Y. Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis. J. Virol. 81 (2007) 4501-4509
133. Sidwell R.W., Barnard D.L., Day C.W., Smee D.F., Bailey K.W., Wong M.H., Morrey J.D., and Furuta Y. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob. Agents Chemother. 51 (2007) 845-851
134. Stiasny K., and Heinz F.X. Flavivirus membrane fusion. J. Gen. Virol. 87 (2006) 2755-2766
135. Stiasny K., Bressanelli S., Lepault J., Rey F.A., and Heinz F.X. Characterization of a membrane-associated trimeric low-pH-induced form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization. J. Virol. 78 (2004) 3178-3183
136. Suzich J.A., Tamura J.K., Palmer Hill F., Warrener P., Grakoui A., Rice C.M., Feinstone S.M., and Collett M.S. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J. Virol. 67 (1993) 6152-6158
137. Takhampunya R., Ubol S., Houng H.S., Cameron C.E., and Padmanabhan R. Inhibition of dengue virus replication by mycophenolic acid and ribavirin. J. Gen. Virol. 87 (2006) 1947-1952
138. Tamura J.K., Warrener P., and Collett M.S. RNA-stimulated NTPase activity associated with the p80 protein of the pestivirus bovine viral diarrhea virus. Virology 193 (1993) 1-10
139. Tan B.H., Fu J.L., Sugrue R.J., Yap E.H., Chan Y.C., and Tan Y.H. Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity. Virology 216 (1996) 317-325
140. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfherer C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., and Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197 (2003) 823-829
141. Uchil P.D., and Satchidanandam V. Architecture of the flaviviral replication complex-protease, nuclease, and detergents reveal encasement within double-layered membrane compartments. J. Biol. Chem. 278 (2003) 24388-24398
142. Umareddy I., Chao A., Sampath A., Gu F., and Vasudevan S.G. Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J. Gen. Virol. 87 (2006) 2605-2614
143. Wang S.H., Syu W.J., Huang K.J., Lei H.Y., Yao C.W., King C.C., and Hu S.T. Intracellular localization and determination of a nuclear localization signal of the core protein of dengue virus. J. Gen. Virol. 83 (2002) 3093-3102
144. Warrener P., Tamura J.K., and Collett M.S. RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria. J. Virol. 67 (1993) 989-996
145. Wengler G., Czaya G., Farber P.M., and Hegemann J.H. In vitro synthesis of West Nile virus proteins indicates that the amino-terminal segment of the NS3 protein contains the active centre of the protease which cleaves the viral polyprotein after multiple basic amino acids. J. Gen. Virol. 72 (1991) 851-858
146. Westaway E.G., MacKenzie J.M., Kenney M.T., Jones M.K., and Khromykh A.A. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J. Virol. 71 (1997) 6650-6661
147. Westaway E.G., Khromykh A.A., and Mackenzie J.M. Nascent flavivirus RNA colocalized in situ with double-stranded RNA in stable replication complexes. Virology 258 (1999) 108-117
148. Wu J.H., Bera A.K., Kuhn R.J., and Smith J.L. Structure of the flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J. Virol. 79 (2005) 10268-10277
149. Wu Y.S., Lin W.H., Hsu J.T., and Hsieh H.P. Antiviral drug discovery against SARS-CoV. Curr. Med. Chem. 13 (2006) 2003-2020
150. Xi X.G. Helicases as antiviral and anticancer drug targets. Curr. Med. Chem. 14 (2007) 883-915
151. Xu T., Sampath A., Chao A., Wen D.Y., Nanao M., Chene P., Vasudevan S.G., and Lescar J. Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 angstrom. J. Virol. 79 (2005) 10278-10288
152. Yamashita T., Unno H., Mori Y., Tani H., Moriishi K., Takamizawa A., Agoh M., Tsukihara T., and Matsuura Y. Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 angstrom. Virology 373 (2008) 426-436
153. Yap T.L., Xu T., Chen Y.L., Malet H., Egloff M.P., Canard B., Vasudevan S.G., and Lescar J. Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-Angstrom resolution. J. Virol. 81 (2007) 4753-4765
154. Yauch L.E., and Shresta S. Mouse models of dengue virus infection and disease. Antiviral Res. 80 (2008) 87-93
155. Yin Z., Patel S.J., Wang W.L., Chan W.L., Ranga Rao K.R., Wang G., Ngew X., Patel V., Beer D., Knox J.E., Ma N.L., Ehrhardt C., Lim S.P., Vasudevan S.G., and Keller T.H. Peptide inhibitors of dengue virus NS3 protease. Part 2. SAR study of tetrapeptide aldehyde inhibitors. Bioorg. Med. Chem. Lett. 16 (2006) 40-43
156. Yin Z., Patel S.J., Wang W.L., Wang G., Chan W.L., Rao K.R., Alam J., Jeyaraj D.A., Ngew X., Patel V., Beer D., Lim S.P., Vasudevan S.G., and Keller T.H. Peptide inhibitors of Dengue virus NS3 protease. Part 1. Warhead. Bioorg. Med. Chem. Lett. 16 (2006) 36-39
157. Yocupicio-Monroy M., Padmanabhan R., Medina F., and del Angel R.M. Mosquito La protein binds to the 3' untranslated region of the positive and negative polarity dengue virus RNAs and relocates to the cytoplasm of infected cells. Virology 357 (2007) 29-40
158. Yon C., Teramoto T., Mueller N., Phelan J., Ganesh V.K., Murthy K.H., and Padmanabhan R. Modulation of the nucleoside triphosphatase/RNA helicase and 5′-RNA triphosphatase activities of dengue virus type 2 nonstructural protein 3 (NS3) by interaction with NS5, the RNA-dependent RNA polymerase. J. Biol. Chem. 280 (2005) 27412-27419
159. You S., and Padmanabhan R. A novel in vitro replication system for Dengue virus. Initiation of RNA synthesis at the 3′-end of exogenous viral RNA templates requires 5′- and 3′-terminal complementary sequence motifs of the viral RNA. J. Biol. Chem. 274 (1999) 33714-33722
160. You S., Falgout B., Markoff L., and Padmanabhan R. In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5′- and 3′-terminal regions that influence RNA structure. J. Biol. Chem. 276 (2001) 15581-15591
161. Yu I.M., Zhang W., Holdaway H.A., Li L., Kostyuchenko V.A., Chipman P.R., Kuhn R.J., Rossmann M.G., and Chen J. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319 (2008) 1834-1837
162. Yu L., Nomaguchi M., Padmanabhan R., and Markoff L. Specific requirements for elements of the 5′ and 3′ terminal regions in flavivirus RNA synthesis and viral replication. Virology 374 (2008) 170-185
163. Yusof R., Clum S., Wetzel M., Murthy H.M., and Padmanabhan R. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J. Biol. Chem. 275 (2000) 9963-9969
164. Zhang L.W., Mohan P.M., and Padmanabhan R. Processing and localization of dengue virus type-2 polyprotein precursor NS3-NS4a-NS4b-NS5. J. Virol. 66 (1992) 7549-7554
165. Zhang N., Chen H.M., Koch V., Schmitz H., Liao C.L., Bretner M., Bhadti V.S., Fattom A.I., Naso R.B., Hosmane R.S., and Borowski P. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against Flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus. J. Med. Chem. 46 (2003) 4149-4164
166. Zhang N., Chen H.M., Koch V., Schmitz H., Minczuk M., Stepien P., Fattom A.I., Naso R.B., Kalicharran K., Borowski P., and Hosmane R.S. Potent inhibition of NTPase/helicase of the West Nile virus by ring-expanded ("Fat") nucleoside analogues. J. Med. Chem. 46 (2003) 4776-4789
167. Zhang B., Dong H., Zhou Y., and Shi P.Y. Genetic interactions among the West Nile virus methyltransferase, the RNA-dependent RNA polymerase, and the 5′ stem-loop of genomic RNA. J. Virol. 82 (2008) 7047-7058
168. Zhou Y.S., Ray D., Zhao Y.W., Dong H.P., Ren S.P., Li Z., Guo Y., Bernard K.A., Shi P.Y., and Li H.M. Structure and function of flavivirus NS5 methyltransferase. J. Virol. 81 (2007) 3891-3903